Bioreducible, Arginine-Rich Polydisulfide-Based siRNA Nanocomplex with Excellent Tumor Penetra-tion for Efficient Gene Silencing

2021 ◽  
Author(s):  
Xinyue Zhang ◽  
Kai Hong ◽  
Qingmei Sun ◽  
Yunqing Zhu ◽  
Jianzhong Du

RNA interference (RNAi) technology has great potential in cancer therapy, e.g., small interfering RNA (siRNA) can be exploited to silence specific oncogenes related to tumor growth and progression. However, it...

2021 ◽  
Vol 2 (2) ◽  
pp. 16-19
Author(s):  
Shazia Choudhary ◽  
Sheeba Murad ◽  
Sana Gul ◽  
Hayat Khan ◽  
Samra Khalid ◽  
...  

RNA interference (RNAi) refers to the inhibition of gene expression by small double-stranded RNA molecules. This technology can prove to be a breakthrough biological discovery of the decade as it has the potential to revolutionize the field of therapeutics. RNA interference (RNAi) through small interfering RNA (siRNA) is currently being evaluated for its efficacy to be used in therapeutics as well as prophylactic strategies. Many studies are being conducted across the globe to optimize the siRNA delivery systems (in terms of safe, stable and efficient delivery) in various disorders. There are a number of diseases such as autoimmune diseases, cancer associated pathological changes, bacterial and viral induced disorders, where RNAi pathway can be explored and RNAi technology can be used as a tool to intervene such abnormalities. This review is an effort to review latest advancements in the field of siRNA based therapy development and the pits and falls generally encountered in the use of this technology.


2010 ◽  
Vol 20 (3) ◽  
pp. 163-172 ◽  
Author(s):  
Bilal Ghosn ◽  
Ankur Singh ◽  
Mu Li ◽  
Alexander V. Vlassov ◽  
Chris Burnett ◽  
...  

2014 ◽  
Vol 165 (1) ◽  
pp. 15-29 ◽  
Author(s):  
Alberto Carbonell ◽  
Atsushi Takeda ◽  
Noah Fahlgren ◽  
Simon C. Johnson ◽  
Josh T. Cuperus ◽  
...  

2011 ◽  
Vol 79 (6) ◽  
pp. 953-963 ◽  
Author(s):  
Jie Wei ◽  
Jeffrey Jones ◽  
Jing Kang ◽  
Ananda Card ◽  
Michael Krimm ◽  
...  

2007 ◽  
Vol 18 (11) ◽  
pp. 4669-4680 ◽  
Author(s):  
Hiroshi Yamada ◽  
Emiko Ohashi ◽  
Tadashi Abe ◽  
Norihiro Kusumi ◽  
Shun-AI Li ◽  
...  

Amphiphysin 1 is involved in clathrin-mediated endocytosis. In this study, we demonstrate that amphiphysin 1 is essential for cellular phagocytosis and that it is critical for actin polymerization. Phagocytosis in Sertoli cells was induced by stimulating phosphatidylserine receptors. This stimulation led to the formation of actin-rich structures, including ruffles, phagocytic cups, and phagosomes, all of which showed an accumulation of amphiphysin 1. Knocking out amphiphysin 1 by RNA interference in the cells resulted in the reduction of ruffle formation, actin polymerization, and phagocytosis. Phagocytosis was also drastically decreased in amph 1 (−/−) Sertoli cells. In addition, phosphatidylinositol-4,5-bisphosphate–induced actin polymerization was decreased in the knockout testis cytosol. The addition of recombinant amphiphysin 1 to the cytosol restored the polymerization process. Ruffle formation in small interfering RNA-treated cells was recovered by the expression of constitutively active Rac1, suggesting that amphiphysin 1 functions upstream of the protein. These findings support that amphiphysin 1 is important in the regulation of actin dynamics and that it is required for phagocytosis.


2007 ◽  
Vol 122 (3) ◽  
pp. 658-663 ◽  
Author(s):  
Kentaro Iwaki ◽  
Kohei Shibata ◽  
Masayuki Ohta ◽  
Yuichi Endo ◽  
Hiroki Uchida ◽  
...  

2004 ◽  
Vol 5 (1) ◽  
pp. 1-7 ◽  
Author(s):  
Bentham Science Publisher Zhang J. ◽  
Bentham Science Publisher Hua Z.C.

FEBS Journal ◽  
2014 ◽  
Vol 282 (1) ◽  
pp. 153-173 ◽  
Author(s):  
Sumit G. Gandhi ◽  
Indira Bag ◽  
Saswati Sengupta ◽  
Manika Pal-Bhadra ◽  
Utpal Bhadra

Sign in / Sign up

Export Citation Format

Share Document